News

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive. 

Breast cancer AI ribbon pink artificial intelligence

Experts believe the tool could better inform surveillance strategies in women who have been treated for breast cancer.

older basketball player

Former NBA player Muggsy Bogues, who also acted in the 1996 film Space Jam, is one of many athletes now participating in the registry. "I’ve lost too many friends to cardiovascular disease," he said. 

Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

Researchers in the U.K. from Newcastle University, University of Leeds, and the University of East Anglia found they could use cardiovascular magnetic resonance (CMR) T2 intracardiac blood pool data to create imaging-derived SvO2 (iSvO2) noninvasively.

Advanced imaging may be able to help certain heart patients avoid the risks and discomfort associated with right heart catheterizations.

phone

Amid work-from-home disparities between interventional and diagnostic rads, researchers recently interviewed hundreds of IRs to learn about the landscape. 

Norwalk Radiology Consultants

Norwalk Radiology Consultants and Stamford Health recently held a ribbon cutting ceremony to celebrate the opening of their renovated joint venture location in Norwalk. 

breast cancer month ribbon

The two join several others that have also done so in 2026 including Alabama, Arizona, California, Hawaii, Rhode Island and South Carolina. 

iron bioresorbable scaffold Biotyx Medical

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC

Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE

It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 

Jane E Wilcox, MD, and Neil G. Bluhm. Image courtesy of Northwestern.

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

Around the web

Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive.